Why the Bloodletting in FAANG Stocks is Just Getting Started

We expect the real pain will come when a clear rotation occurs. This rotation should get under way when it becomes clear that earnings growth for FAANGs and other technology names in 2019 do not live up to expectations,” said the Canaccord analysts. And that second wave of selling should start in January when fourth-quarter results start rolling out, they say.

 

https://www.marketwatch.com/story/why-the-bloodletting-from-faang-stocks-is-just-getting-started-canaccord-2018-11-28